Stock DNA
Pharmaceuticals & Biotechnology
CNY 17,354 Million (Large Cap)
23.00
NA
0.53%
-0.46
3.41%
0.80
Revenue and Profits:
Net Sales:
258 Million
(Quarterly Results - Jun 2025)
Net Profit:
642 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.41%
0%
-3.41%
6 Months
-4.38%
0%
-4.38%
1 Year
-2.06%
0%
-2.06%
2 Years
-0.39%
0%
-0.39%
3 Years
-36.05%
0%
-36.05%
4 Years
413.71%
0%
413.71%
5 Years
296.89%
0%
296.89%
Andon Health Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.09%
EBIT Growth (5y)
-25.97%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.15
Tax Ratio
14.26%
Dividend Payout Ratio
5.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
109.99%
ROE (avg)
25.58%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
0.80
EV to EBIT
190.72
EV to EBITDA
69.84
EV to Capital Employed
0.62
EV to Sales
3.68
PEG Ratio
NA
Dividend Yield
0.53%
ROCE (Latest)
0.33%
ROE (Latest)
3.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
257.50
506.20
-49.13%
Operating Profit (PBDIT) excl Other Income
-178.10
49.40
-460.53%
Interest
35.60
19.00
87.37%
Exceptional Items
677.50
56.10
1,107.66%
Consolidate Net Profit
642.40
277.80
131.25%
Operating Profit Margin (Excl OI)
-769.40%
57.90%
-82.73%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -49.13% vs 2.08% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 131.25% vs 4.24% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,585.60
3,186.40
-18.86%
Operating Profit (PBDIT) excl Other Income
742.50
857.10
-13.37%
Interest
69.40
15.20
356.58%
Exceptional Items
710.90
101.00
603.86%
Consolidate Net Profit
1,800.00
1,349.20
33.41%
Operating Profit Margin (Excl OI)
260.80%
235.20%
2.56%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -18.86% vs -87.89% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 33.41% vs -91.82% in Dec 2023
About Andon Health Co., Ltd. 
Andon Health Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






